Zhu, Z., Younas, L. & Zhou, Q. Evolution and regulation of animal sex chromosomes. Nat. Rev. Genet. 26, 59–74 (2025).
Google Scholar
Colaco, S. & Modi, D. Genetics of the human Y chromosome and its association with male infertility. Reprod. Biol. Endocrinol. 16, 14 (2018).
Google Scholar
Gutierrez-Hurtado, I. A. et al. Loss of the Y chromosome: a review of molecular mechanisms, age inference, and implications for men’s health. Int. J. Mol. Sci. https://doi.org/10.3390/ijms25084230 (2024).
Google Scholar
Cechova, M. et al. Dynamic evolution of great ape Y chromosomes. Proc. Natl Acad. Sci. USA 117, 26273–26280 (2020).
Google Scholar
Bonito, M. et al. New insights into the evolution of human Y chromosome palindromes through mutation and gene conversion. Hum. Mol. Genet. 30, 2272–2285 (2021).
Google Scholar
Ghenu, A. H., Bolker, B. M., Melnick, D. J. & Evans, B. J. Multicopy gene family evolution on primate Y chromosomes. BMC Genomics 17, 157 (2016).
Google Scholar
Jacobs, P. A., Brunton, M., Court Brown, W. M., Doll, R. & Goldstein, H. Change of human chromosome count distribution with age: evidence for a sex difference. Nature 197, 1080–1081 (1963).
Google Scholar
Thompson, D. J. et al. Genetic predisposition to mosaic Y chromosome loss in blood. Nature 575, 652–657 (2019).
Google Scholar
Fukami, M. & Miyado, M. Mosaic loss of the Y chromosome and men’s health. Reprod. Med. Biol. 21, e12445 (2022).
Google Scholar
Forsberg, L. A. et al. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Nat. Genet. 46, 624–628 (2014). This study is the first description of an association between LOY in peripheral blood with risks of all-cause mortality and solid cancer risk, suggesting that haematopoietic LOY may serve as a predictive biomarker of male carcinogenesis.
Google Scholar
Danielsson, M. et al. Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals. Eur. J. Hum. Genet. 28, 349–357 (2020). This longitudinal study for up to 22 years of haematopoietic LOY demonstrates a marked individual variation and participant-specific changes in LOY frequency, with some males showing a reduction of LOY abundance over time, suggesting a reversible nature of LOY.
Google Scholar
Chen, X. et al. Concurrent loss of the Y chromosome in cancer and T cells impacts outcome. Nature 642, 1041–1050 (2025). Pan-cancer analyses and mouse models revealed that LOY in immune and tumour cells drives T cell immunosuppression, with LOY magnitude in epithelial, CD4⁺ T and CD8⁺ T cells independently predicting survival, while concurrent LOY in both compartments marked the poorest outcomes, linking haematopoietic LOY to increased cancer mortality.
Google Scholar
Song, M. et al. Loss of Y chromosome in leukocytes can be regarded as a male-specific age predictor for age group estimation in forensic genetics. Mol. Genet. Genom. 298, 1073–1085 (2023).
Google Scholar
Cagan, A. et al. Somatic mutation rates scale with lifespan across mammals. Nature 604, 517–524 (2022).
Google Scholar
Wong, J. Y. Y. et al. Outdoor air pollution and mosaic loss of chromosome Y in older men from the cardiovascular health study. Environ. Int. 116, 239–247 (2018).
Google Scholar
Dumanski, J. P. et al. Mutagenesis. Smoking is associated with mosaic loss of chromosome Y. Science 347, 81–83 (2015).
Google Scholar
Loftfield, E. et al. Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank. Sci. Rep. 8, 12316 (2018).
Google Scholar
Chang, V. C. et al. Glyphosate use and mosaic loss of chromosome Y among male farmers in the agricultural health study. Environ. Health Perspect. 131, 127006 (2023).
Google Scholar
Aly, M. S., Khaled, H. M., Emara, M. & Hussein, T. D. Cytogenetic profile of locally advanced and metastatic Schistosoma-related bladder cancer and response to chemotherapy. Cancer Genet. 205, 156–162 (2012).
Google Scholar
Ruiz-Herrera, A. & Waters, P. D. Fragile, unfaithful and persistent Ys—on how meiosis can shape sex chromosome evolution. Heredity 129, 22–30 (2022).
Google Scholar
Blackmon, H. & Brandvain, Y. Long-term fragility of Y chromosomes is dominated by short-term resolution of sexual antagonism. Genetics 207, 1621–1629 (2017).
Google Scholar
Ly, P. et al. Selective Y centromere inactivation triggers chromosome shattering in micronuclei and repair by non-homologous end joining. Nat. Cell Biol. 19, 68–75 (2017).
Google Scholar
Xu, Y. & Pang, Q. Repetitive DNA sequences in the human y chromosome and male infertility. Front. Cell Dev. Biol. 10, 831338 (2022).
Google Scholar
Wiktor, A. et al. Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosomes Cancer 27, 11–16 (2000).
Google Scholar
Ambinder, A. & DeZern, A. CHIPs-A-LOY loss of chromosome Y clusters with CHIP-associated mutations. Hematologist https://doi.org/10.1182/hem.V17.4.12884901909 (2020).
Google Scholar
Wright, D. J. et al. Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility. Nat. Genet. 49, 674–679 (2017).
Google Scholar
Bruhn-Olszewska, B. et al. The effects of loss of Y chromosome on male health. Nat. Rev. Genet. 26, 320–335 (2025). This Review article highlights the effects of LOY on male health and summarizes current methodologies for LOY detection.
Google Scholar
Dumanski, J. P. et al. Immune cells lacking Y chromosome show dysregulation of autosomal gene expression. Cell. Mol. Life Sci. 78, 4019–4033 (2021). In this study, LOY in leukocytes was found to be associated with dysregulation of approximately 500 autosomal genes critical for immune function, with disease-specific and cell type-specific enrichment of LOY indicating context-dependent effects.
Google Scholar
Lau, Y. C. Y chromosome in health and diseases. Cell Biosci. 10, 97 (2020).
Google Scholar
Abdel-Hafiz, H. A. et al. Y chromosome loss in cancer drives growth by evasion of adaptive immunity. Nature 619, 624–631 (2023). This study provides the first mechanistic evidence using LOY mouse models that LOY promotes bladder cancer growth by inducing T cell dysfunction and exhaustion, thereby sensitizing LOY tumours to PD1-targeted immunotherapy.
Google Scholar
Ljungstrom, V. et al. Loss of Y and clonal hematopoiesis in blood-two sides of the same coin?. Leukemia 36, 889–891 (2022).
Google Scholar
Muller, P. et al. Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome. Comput. Struct. Biotechnol. J. 21, 1573–1583 (2023). The first study to examine the prevalence and clinical impact of LOY in tumors across a pan-cancer setting and show differences across cancer types.
Google Scholar
Jakubek, Y. A. et al. Genomic and phenotypic correlates of mosaic loss of chromosome Y in blood. Am. J. Hum. Genet. 112, 276–290 (2025). Using WGS data, this study reports differences in mLOY frequencies across different genetic ancestries and identified multiple loci associated with LOY susceptibility, which are enriched in specific subsets of human haematopoietic stem cells.
Google Scholar
Qi, M., Pang, J., Mitsiades, I., Lane, A. A. & Rheinbay, E. Loss of chromosome Y in primary tumors. Cell https://doi.org/10.1016/j.cell.2023.06.006 (2023). This study provides a comprehensive catalogue of LOY across more than 5,000 primary tumors, demonstrating that LOY rates vary by tumor type.
Google Scholar
Terao, C. et al. GWAS of mosaic loss of chromosome Y highlights genetic effects on blood cell differentiation. Nat. Commun. 10, 4719 (2019).
Google Scholar
Brown, D. W. & Machiela, M. J. Why Y? Downregulation of chromosome Y genes potentially contributes to elevated cancer risk. J. Natl Cancer Inst. 112, 871–872 (2020).
Google Scholar
Caceres, A., Jene, A., Esko, T., Perez-Jurado, L. A. & Gonzalez, J. R. Extreme downregulation of chromosome Y and Alzheimer’s disease in men. Neurobiol. Aging 90, 150.e151–150.e154 (2020).
Google Scholar
Caceres, A., Jene, A., Esko, T., Perez-Jurado, L. A. & Gonzalez, J. R. Extreme downregulation of chromosome Y and cancer risk in men. J. Natl Cancer Inst. 112, 913–920 (2020). This study identifies EDY as a signature of cancer susceptibility in males and proposes EDY as functional mediator linking DNA-based LOY to increased cancer risk.
Google Scholar
Gonzalez, J. R. et al. MADloy: robust detection of mosaic loss of chromosome Y from genotype-array-intensity data. BMC Bioinformatics 21, 533 (2020).
Google Scholar
Moller, A. P., Fincher, C. L. & Thornhill, R. Why men have shorter lives than women: effects of resource availability, infectious disease, and senescence. Am. J. Hum. Biol. 21, 357–364 (2009).
Google Scholar
Parker, K., Erzurumluoglu, A. M. & Rodriguez, S. The Y chromosome: a complex locus for genetic analyses of complex human traits. Genes https://doi.org/10.3390/genes11111273 (2020).
Google Scholar
Ali, S. & Hasnain, S. E. Genomics of the human Y-chromosome: 1. Association with male infertility. Gene 321, 25–37 (2003).
Google Scholar
Hozakowska-Roszkowska, D. M. et al. Mosaic loss of Y chromosome and the association to mortality in Danish men aged 56-100 years. Mech. Ageing Dev. 222, 111979 (2024).
Google Scholar
Loftfield, E. et al. Mosaic Y loss is moderately associated with solid tumor risk. Cancer Res. 79, 461–466 (2019).
Google Scholar
Kuznetsova, I. L., Uralsky, L. I., Tyazhelova, T. V., Andreeva, T. V. & Rogaev, E. I. Mosaic loss of the Y chromosome in human neurodegenerative and oncological diseases. Vavilovskii Zhurnal Genet. Selektsii 27, 502–511 (2023).
Google Scholar
Duan, Q. et al. Mosaic loss of chromosome Y in peripheral blood cells is associated with age-related macular degeneration in men. Cell Biosci. 12, 73 (2022).
Google Scholar
Sano, S. et al. Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality. Science 377, 292–297 (2022). This study establishes a mouse model for haematopoietic LOY by reconstituting the bone marrow of irradiated mice with LOY HSPCs, resulting in LOY in recipient mice that were subsequently used to provide causal evidence that LOY can initiate or aggravate cardiac disease.
Google Scholar
Vermeulen, M. C., Pearse, R., Young-Pearse, T. & Mostafavi, S. Mosaic loss of chromosome Y in aged human microglia. Genome Res. 32, 1795–1807 (2022).
Google Scholar
Wang, Y. & Sano, S. Why Y matters? The implication of loss of Y chromosome in blood and cancer. Cancer Sci. 115, 706–714 (2024).
Google Scholar
Hussain, S. M. et al. Loss of Y chromosome and major cardiovascular events in a prospective study of older men. J. Am. Coll. Cardiol. 87, 36–45 (2026).
Google Scholar
Dumanski, J. P. et al. Mosaic loss of chromosome Y in blood is associated with alzheimer disease. Am. J. Hum. Genet. 98, 1208–1219 (2016).
Google Scholar
Hollows, R. et al. Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma. Head Neck 41, 993–1006 (2019).
Google Scholar
Feng, X. et al. Y-chromosome-linked genes are associated with sex-related head-neck squamous cell carcinoma survival. Otolaryngol. Head Neck Surg. 169, 1533–1541 (2023).
Google Scholar
Lin, S. H. et al. Incident disease associations with mosaic chromosomal alterations on autosomes, X and Y chromosomes: insights from a phenome-wide association study in the UK Biobank. Cell Biosci. 11, 143 (2021).
Google Scholar
Klatte, T. et al. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J. Clin. Oncol. 27, 746–753 (2009).
Google Scholar
Qin, N. et al. Association of mosaic loss of chromosome Y with lung cancer risk and prognosis in a chinese population. J. Thorac. Oncol. 14, 37–44 (2019).
Google Scholar
Mas-Peiro, S. et al. Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement. Eur. Heart J. 44, 1943–1952 (2023).
Google Scholar
Weyrich, M. et al. Loss of Y chromosome and cardiovascular events in chronic kidney disease. Circulation 150, 746–757 (2024).
Google Scholar
Bellott, D. W. et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature 508, 494–499 (2014).
Google Scholar
Skaletsky, H. et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423, 825–837 (2003).
Google Scholar
Kido, T. & Lau, Y. C. The human testis-specific protein Y-linked (TSPY) is a male-specific cancer-testis antigen capable of eliciting significant immune responses and elimination of positive tumor cells in hepatocellular carcinoma. Cell Biosci. 15, 88 (2025).
Google Scholar
Westemeier-Rice, E. S. et al. Lnc-RAINY regulates genes involved in radiation susceptibility through DNA:DNA:RNA triplex-forming interactions and has tumor therapeutic potential in lung cancers. Noncoding RNA Res. 12, 152–166 (2025).
Google Scholar
Rhie, A. et al. The complete sequence of a human Y chromosome. Nature 621, 344–354 (2023). The Telomere-to-Telomere (T2T) consortium reports the complete 62,460,029-base-pair sequence of a human Y chromosome, correcting numerous errors and gaps present in the previous Genome Reference Consortium Human Build 38 (GRCh38-Y) assembly and adding more than 30 million base pairs of sequence and 41 additional protein-coding genes.
Google Scholar
Westemeier-Rice, E. S., Winters, M. T., Rawson, T. W. & Martinez, I. More than the SRY: the non-coding landscape of the Y chromosome and its importance in human disease. Noncoding RNA https://doi.org/10.3390/ncrna10020021 (2024).
Google Scholar
Willis-Owen, S. A. G. et al. Y disruption, autosomal hypomethylation and poor male lung cancer survival. Sci. Rep. 11, 12453 (2021).
Google Scholar
Jakalski, M. et al. DNA methylation patterns contribute to changes of cellular differentiation pathways in leukocytes with LOY from patients with Alzheimer’s disease. Cell Mol. Life Sci. 82, 93 (2025).
Google Scholar
Batdorj, E. et al. Genetic variation in the Y chromosome and sex-biased DNA methylation in somatic cells in the mouse. Mamm. Genome 34, 44–55 (2023).
Google Scholar
Walport, L. J. et al. Human UTY(KDM6C) is a male-specific Nє-methyl lysyl demethylase. J. Biol. Chem. 289, 18302–18313 (2014).
Google Scholar
Harmeyer, K. M., Facompre, N. D., Herlyn, M. & Basu, D. JARID1 histone demethylases: emerging targets in cancer. Trends Cancer 3, 713–725 (2017).
Google Scholar
Jensen, L. R. et al. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 76, 227–236 (2005).
Google Scholar
Gozdecka, M. et al. UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. Nat. Genet. 50, 883–894 (2018).
Google Scholar
Komura, K. et al. ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D. J. Clin. Invest. 128, 2979–2995 (2018).
Google Scholar
Komura, K. et al. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression. Proc. Natl Acad. Sci. USA 113, 6259–6264 (2016).
Google Scholar
Ohguchi, Y. & Ohguchi, H. Diverse functions of KDM5 in cancer: transcriptional repressor or activator?. Cancers https://doi.org/10.3390/cancers14133270 (2022).
Google Scholar
Ura, A. et al. Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma. J. Pathol. Clin. Res. 10, e350 (2024).
Google Scholar
Li, J. et al. Histone demethylase KDM5D upregulation drives sex differences in colon cancer. Nature 619, 632–639 (2023).
Google Scholar
Schafer, G., Bednarova, N., Heidenreich, A., Klocker, H. & Heidegger, I. KDM5D predicts response to docetaxel chemotherapy in metastatic castration resistant prostate cancer patients. Transl. Androl. Urol. 10, 3946–3952 (2021).
Google Scholar
Yoshikawa, Y. et al. Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer. Mol. Oncol. 16, 3994–4010 (2022).
Google Scholar
Chen, J. et al. KDM5D histone demethylase mediates p38alpha inactivation via its enzymatic activity to inhibit cancer progression. Proc. Natl Acad. Sci. USA 121, e2402022121 (2024).
Google Scholar
Case, L. K. et al. The Y chromosome as a regulatory element shaping immune cell transcriptomes and susceptibility to autoimmune disease. Genome Res. 23, 1474–1485 (2013).
Google Scholar
Mattisson, J. et al. Leukocytes with chromosome Y loss have reduced abundance of the cell surface immunoprotein CD99. Sci. Rep. 11, 15160 (2021).
Google Scholar
Mattisson, J. et al. Loss of chromosome Y in regulatory T cells. BMC Genomics 25, 243 (2024). Utilizing scRNA-seq datasets from patients with cancer, this study shows that Treg cells are particularly affected by LOY, leading to dysregulated gene expression and altered lymphocyte differentiation, which may contribute to the increased cancer risk observed in males with leukocyte LOY.
Google Scholar
Lin, S.-H. et al. Mosaic chromosome Y loss is associated with alterations in blood cell counts in UK Biobank men. Sci. Rep. 10, 3655 (2020). This population-based study reports that LOY is associated with altered blood cell counts independent of age, which may contribute to the increased risk of cancer and other chronic diseases in males.
Google Scholar
Bruhn-Olszewska, B. et al. Loss of Y in leukocytes as a risk factor for critical COVID-19 in men. Genome Med. 14, 139 (2022).
Google Scholar
Giannakeas, V. et al. Analysis of platelet count and new cancer diagnosis over a 10-year period. JAMA Netw. Open 5, e2141633 (2022).
Google Scholar
Mounce, L. T., Hamilton, W. & Bailey, S. E. Cancer incidence following a high-normal platelet count: cohort study using electronic healthcare records from english primary care. Br. J. Gen. Pract. 70, e622–e628 (2020).
Google Scholar
Autissier, P., Soulas, C., Burdo, T. H. & Williams, K. C. Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans. Cytometry A 77, 410–419 (2010).
Google Scholar
Saleh, M. N. et al. CD16 + monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood 85, 2910–2917 (1995).
Google Scholar
Coffelt, S. B., Wellenstein, M. D. & de Visser, K. E. Neutrophils in cancer: neutral no more. Nat. Rev. Cancer 16, 431–446 (2016).
Google Scholar
Wojcik, M. et al. Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases. Sci. Rep. 14, 9458 (2024).
Google Scholar
Dirican, C. D. & Nelson, P. S. Y chromosome loss and implications for oncology. Mol. Cancer Res. 22, 603–612 (2024).
Google Scholar
Requesens, M., Foijer, F., Nijman, H. W. & de Bruyn, M. Genomic instability as a driver and suppressor of anti-tumor immunity. Front. Immunol. 15, 1462496 (2024).
Google Scholar
Stankowska, W. et al. Tumor predisposing post-zygotic chromosomal alterations in bladder cancer-insights from histologically normal urothelium. Cancers https://doi.org/10.3390/cancers16050961 (2024).
Google Scholar
Zheng, C. et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell 169, 1342–1356 (2017).
Google Scholar
Federico, L. et al. Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer. Ann. Oncol. 33, 42–56 (2022).
Google Scholar
Bhattacharya, S., Sadhukhan, D. & Saraswathy, R. Role of sex in immune response and epigenetic mechanisms. Epigenetics Chromatin 17, 1 (2024).
Google Scholar
Kutch, I. C. & Fedorka, K. M. Y-linked variation for autosomal immune gene regulation has the potential to shape sexually dimorphic immunity. Proc. Biol. Sci. 282, 20151301 (2015).
Google Scholar
Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16, 626–638 (2016).
Google Scholar
Milatovich, A., Kitamura, T., Miyajima, A. & Francke, U. Gene for the alpha-subunit of the human interleukin-3 receptor (IL3RA) localized to the X-Y pseudoautosomal region. Am. J. Hum. Genet. 53, 1146–1153 (1993).
Google Scholar
Winschel, I. et al. Sex- and species-specific contribution of CD99 to T cell costimulation during multiple sclerosis. Biol. Sex Differ. 15, 41 (2024).
Google Scholar
Rappold, G., Willson, T. A., Henke, A. & Gough, N. M. Arrangement and localization of the human GM-CSF receptor alpha chain gene CSF2RA within the X–Y pseudoautosomal region. Genomics 14, 455–461 (1992).
Google Scholar
Zou, R., Wu, Q., Fang, F. & Cao, Y. Systematic pan-cancer analysis of IL3RA carcinogenesis in human tumors, combined with bioinformatics analysis. Discov. Oncol. 16, 2345 (2025).
Google Scholar
Rosinski, K. V. et al. DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells. Blood 111, 4817–4826 (2008).
Google Scholar
Li, Q. et al. Specific expression and alternative splicing of mouse genes during spermatogenesis. Mol. Omics 16, 258–267 (2020).
Google Scholar
Dawoud, A. A. Z., Tapper, W. J. & Cross, N. C. P. Age-related loss of chromosome Y is associated with levels of sex hormone binding globulin and clonal hematopoiesis defined by TET2, TP53, and CBL mutations. Sci. Adv. 9, eade9746 (2023).
Google Scholar
Urrutia, S., Wong, T. N. & Link, D. C. A clinical guide to TP53 mutations in myeloid neoplasms. Blood 146, 2157–2167 (2025).
Google Scholar
Guo, X. & Dai, X. A complex systems approach to mosaic loss of the Y chromosome. Geroscience 47, 631–651 (2025).
Google Scholar
Matsumoto, T. et al. The androgen receptor in health and disease. Annu. Rev. Physiol. 75, 201–224 (2013).
Google Scholar
Ben-Batalla, I., Vargas-Delgado, M. E., von Amsberg, G., Janning, M. & Loges, S. Influence of androgens on immunity to self and foreign: effects on immunity and cancer. Front. Immunol. 11, 1184 (2020).
Google Scholar
Becerra-Diaz, M., Song, M. & Heller, N. Androgen and androgen receptors as regulators of monocyte and macrophage biology in the healthy and diseased lung. Front. Immunol. 11, 1698 (2020).
Google Scholar
Gubbels Bupp, M. R. & Jorgensen, T. N. Androgen-induced immunosuppression. Front. Immunol. 9, 794 (2018).
Google Scholar
Armstrong, C. M. & Gao, A. C. Dysregulated androgen synthesis and anti-androgen resistance in advanced prostate cancer. Am. J. Clin. Exp. Urol. 9, 292–300 (2021).
Google Scholar
Sas-Korczynska, B. et al. Androgen receptor in male breast cancer. Pol. J. Pathol. 66, 347–352 (2015).
Google Scholar
Wenhui, Z. et al. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment. Eur. J. Endocrinol. 171, 527–533 (2014).
Google Scholar
Lobaccaro, J. M. et al. Androgen receptor gene mutation in male breast cancer. Hum. Mol. Genet. 2, 1799–1802 (1993).
Google Scholar
Takuwa, H., Tsuji, W., Shintaku, M. & Yotsumoto, F. Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: a case report. BMC Cancer 18, 1282 (2018).
Google Scholar
Li, Y., Izumi, K. & Miyamoto, H. The role of the androgen receptor in the development and progression of bladder cancer. Jpn. J. Clin. Oncol. 42, 569–577 (2012).
Google Scholar
Li, Y. et al. Androgen activates beta-catenin signaling in bladder cancer cells. Endocr. Relat. Cancer 20, 293–304 (2013).
Google Scholar
Thiebaut, C., Vlaeminck-Guillem, V., Tredan, O., Poulard, C. & Le Romancer, M. Non-genomic signaling of steroid receptors in cancer. Mol. Cell. Endocrinol. 538, 111453 (2021).
Google Scholar
Celestra, D. et al. Epigenetic remodeling by sex hormone receptors and implications for gender affirming hormone therapy. Front. Immunol. 16, 1501959 (2025).
Google Scholar
Hunter, I., Jamieson, C. & McEwan, I. J. The androgen receptor amino-terminal domain: structure, function and therapeutic potential. Endocr. Oncol. 5, e240061 (2025).
Google Scholar
Li, Y., Zhang, D. J., Qiu, Y., Kido, T. & Lau, Y. C. The Y-located proto-oncogene TSPY exacerbates and its X-homologue TSPX inhibits transactivation functions of androgen receptor and its constitutively active variants. Hum. Mol. Genet. 26, 901–912 (2017).
Google Scholar
Giachini, C. et al. TSPY1 copy number variation influences spermatogenesis and shows differences among Y lineages. J. Clin. Endocrinol. Metab. 94, 4016–4022 (2009).
Google Scholar
Tu, W. et al. Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression. Cancer Sci. 110, 1573–1586 (2019).
Google Scholar
Kido, T. & Lau, Y. C. The Y-linked proto-oncogene TSPY contributes to poor prognosis of the male hepatocellular carcinoma patients by promoting the pro-oncogenic and suppressing the anti-oncogenic gene expression. Cell Biosci. 9, 22 (2019).
Google Scholar
Shen, Y. et al. TSPY1 suppresses USP7-mediated p53 function and promotes spermatogonial proliferation. Cell Death Dis. 9, 542 (2018).
Google Scholar
Kido, T. & Lau, Y. F. The human Y-encoded testis-specific protein interacts functionally with eukaryotic translation elongation factor eEF1A, a putative oncoprotein. Int. J. Cancer 123, 1573–1585 (2008).
Google Scholar
Li, Y. & Lau, Y. F. TSPY and its X-encoded homologue interact with cyclin B but exert contrasting functions on cyclin-dependent kinase 1 activities. Oncogene 27, 6141–6150 (2008).
Google Scholar
Oram, S. W., Liu, X. X., Lee, T. L., Chan, W. Y. & Lau, Y. F. TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer 6, 154 (2006).
Google Scholar
Kobayashi, T., Hachiya, T., Ikehata, Y. & Horie, S. Genetic association of mosaic loss of chromosome Y with prostate cancer in men of European and East Asian ancestries: a Mendelian randomization study. Front. Aging 4, 1176451 (2023).
Google Scholar
Fischer, J. et al. Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigens. Preprint at bioRxiv https://doi.org/10.1101/2024.09.19.613876 (2024).
Noveski, P. et al. Loss of Y chromosome in peripheral blood of colorectal and prostate cancer patients. PLoS ONE 11, e0146264 (2016).
Google Scholar
de Lange, J. et al. High levels of Hdmx promote cell growth in a subset of uveal melanomas. Am. J. Cancer Res. 2, 492–507 (2012).
Google Scholar
Arnold, A. P. & Chen, X. What does the “four core genotypes” mouse model tell us about sex differences in the brain and other tissues?. Front. Neuroendocrinol. 30, 1–9 (2009).
Google Scholar
Arnold, A. P. Four core genotypes and XY* mouse models: update on impact on SABV research. Neurosci. Biobehav. Rev. 119, 1–8 (2020).
Google Scholar
Kwon, H. et al. Androgen conspires with the CD8( + ) T cell exhaustion program and contributes to sex bias in cancer. Sci. Immunol. 7, eabq2630 (2022).
Google Scholar
Gregorova, S. et al. Mouse consomic strains: exploiting genetic divergence between Mus m. musculus and Mus m. domesticus subspecies. Genome Res. 18, 509–515 (2008).
Google Scholar
Zuo, E. et al. CRISPR/Cas9-mediated targeted chromosome elimination. Genome Biol. 18, 224 (2017). This study provides proof of concept that CRISPR–Cas9 can efficiently eliminate specific chromosomes in cultured cells, embryos and tissues in vivo.
Google Scholar
Adikusuma, F., Williams, N., Grutzner, F., Hughes, J. & Thomas, P. Targeted deletion of an entire chromosome using CRISPR/Cas9. Mol. Ther. 25, 1736–1738 (2017). This study provides proof of concept for efficient CRISPR–Cas9-mediated chromosome deletion via chromosomal shredding or centromere deletion in mouse embryonic stem cells and zygotes, laying the groundwork for the generation of Y-deficient models.
Google Scholar
Sano, S. & Walsh, K. Development of a mouse model of hematopoietic loss of y chromosome. Bio Protoc. 13, e4729 (2023).
Google Scholar
Abdel-Hafiz, H. A. et al. Single-cell profiling of murine bladder cancer identifies sex-specific transcriptional signatures with prognostic relevance. iScience 26, 107703 (2023).
Google Scholar
Shankaran, V. et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107–1111 (2001).
Google Scholar
Giam, M. & Rancati, G. Aneuploidy and chromosomal instability in cancer: a jackpot to chaos. Cell Div. 10, 3 (2015).
Google Scholar
Zhang, Q. et al. Mosaic loss of chromosome Y promotes leukemogenesis and clonal hematopoiesis. JCI Insight https://doi.org/10.1172/jci.insight.153768 (2022). This study uses mouse CRISPR–Cas9-mediated LOY HSPCs to demonstrate LOY is a functional driver for clonal haematopoiesis and leukemogenesis.
Google Scholar
Celli, L., Gasparini, P., Biino, G., Zannini, L. & Cardano, M. CRISPR/Cas9 mediated Y-chromosome elimination affects human cells transcriptome. Cell Biosci. 14, 15 (2024). Using a CRISPR–Cas9-engineered Y-deficient human male retinal epithelial cell line, this study demonstrates that LOY drives widespread transcriptomic alterations in pathways regulating cell migration, angiogenesis, immune response and DNA damage signalling.
Google Scholar
Guo, C., Ma, X., Gao, F. & Guo, Y. Off-target effects in CRISPR/Cas9 gene editing. Front. Bioeng. Biotechnol. 11, 1143157 (2023).
Google Scholar
Hunt, J. M. T., Samson, C. A., Rand, A. D. & Sheppard, H. M. Unintended CRISPR–Cas9 editing outcomes: a review of the detection and prevalence of structural variants generated by gene-editing in human cells. Hum. Genet. 142, 705–720 (2023).
Google Scholar
Asmamaw Mengstie, M. et al. Recent advancements in reducing the off-target effect of CRISPR–Cas9 genome editing. Biologics 18, 21–28 (2024).
Google Scholar
Bhasin, S., Ma, K. & de Kretser, D. M. Y-chromosome microdeletions and male infertility. Ann. Med. 29, 261–263 (1997).
Google Scholar
Kleiman, S. E. et al. Screening for partial AZFa microdeletions in the Y chromosome of infertile men: is it of clinical relevance?. Fertil. Steril. 98, 43–47 (2012).
Google Scholar
Johnsson, P., Lipovich, L., Grander, D. & Morris, K. V. Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim. Biophys. Acta 1840, 1063–1071 (2014).
Google Scholar
Soh, Y. Q. et al. Sequencing the mouse Y chromosome reveals convergent gene acquisition and amplification on both sex chromosomes. Cell 159, 800–813 (2014).
Google Scholar
Hughes, J. F. et al. Chimpanzee and human Y chromosomes are remarkably divergent in structure and gene content. Nature 463, 536–539 (2010).
Google Scholar
Seah, I., Goh, D., Chan, H. W. & Su, X. Developing non-human primate models of inherited retinal diseases. Genes https://doi.org/10.3390/genes13020344 (2022).
Google Scholar
Hughes, J. F., Skaletsky, H. & Page, D. C. Sequencing of rhesus macaque Y chromosome clarifies origins and evolution of the DAZ (Deleted in AZoospermia) genes. Bioessays 34, 1035–1044 (2012).
Google Scholar
Hughes, J. F. et al. Strict evolutionary conservation followed rapid gene loss on human and rhesus Y chromosomes. Nature 483, 82–86 (2012).
Google Scholar
Orta, A. H. et al. Rats exhibit age-related mosaic loss of chromosome Y. Commun. Biol. 4, 1418 (2021).
Google Scholar
Dupont, C. et al. Incidence of chromosomal mosaicism in morphologically normal nonhuman primate preimplantation embryos. Fertil. Steril. 93, 2545–2550 (2010).
Google Scholar
Yang, C. et al. Evolutionary and biomedical insights from a marmoset diploid genome assembly. Nature 594, 227–233 (2021).
Google Scholar
Tsai, K. L., Evans, J. M., Noorai, R. E., Starr-Moss, A. N. & Clark, L. A. Novel Y chromosome retrocopies in canids revealed through a genome-wide association study for sex. Genes https://doi.org/10.3390/genes10040320 (2019).
Google Scholar
Forsberg, L. A. Loss of chromosome Y (LOY) in blood cells is associated with increased risk for disease and mortality in aging men. Hum. Genet. 136, 657–663 (2017).
Google Scholar
Demanelis, K. et al. Somatic loss of the Y chromosome is associated with arsenic exposure among Bangladeshi men. Int. J. Epidemiol. 52, 1035–1046 (2023).
Google Scholar
Hurwitz, L. M. et al. Organochlorine pesticide use and mosaic loss of chromosome Y in a study of male farmers. Environ. Res. 277, 121539 (2025).
Google Scholar
Lleo, A. et al. Y chromosome loss in male patients with primary biliary cirrhosis. J. Autoimmun. 41, 87–91 (2013).
Google Scholar
Persani, L. et al. Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis. J. Autoimmun. 38, J193–J196 (2012).
Google Scholar
Perez-Jurado, L. A. et al. Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2. Commun. Biol. 7, 202 (2024).
Google Scholar
San Roman, A. K. et al. The human Y and inactive X chromosomes similarly modulate autosomal gene expression. Cell Genom. 4, 100462 (2024).
Google Scholar
Arseneault, M. et al. Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma. Sci. Rep. 7, 44876 (2017).
Google Scholar
Gole, L. A. & Ng, S. C. FISH analysis of Y chromosome long arm deletions in subfertile men considering ICSI. A report of two cases. J. Reprod. Med. 47, 515–518 (2002).
Google Scholar
Zhou, W., Huang, W. Y., Freedman, N. D. & Machiela, M. Estimation of mosaic loss of Y chromosome cell fraction with genotyping arrays lacking coverage in the pseudoautosomal region. BMC Bioinformatics 26, 60 (2025).
Google Scholar
Balciuniene, J. et al. Cancer cytogenetics in a genomics world: wedding the old with the new. Blood Rev. 66, 101209 (2024).
Google Scholar
Guo, X., Li, J., Xue, J., Fenech, M. & Wang, X. Loss of Y chromosome: an emerging next-generation biomarker for disease prediction and early detection?. Mutat. Res. Rev. Mutat. Res. 788, 108389 (2021).
Google Scholar
Weng, C. et al. Mosaic loss of chromosome Y, tobacco smoking and risk of age-related lung diseases: insights from two prospective cohorts. Eur. Respir. J. https://doi.org/10.1183/13993003.00968-2024 (2024).
Google Scholar
Timonina, V., Marchal, A., Abel, L., Cobat, A. & Fellay, J. MosCoverY: a method to estimate mosaic loss of Y chromosome from sequencing coverage data. Am. J. Hum. Genet. 112, 2509–2519 (2025).
Google Scholar
Osipov, A. et al. The molecular twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients. Nat. Cancer 5, 299–314 (2024).
Google Scholar
Unnikrishnan, A. et al. The role of DNA methylation in epigenetics of aging. Pharmacol. Ther. 195, 172–185 (2019).
Google Scholar
Li, G. et al. Age-related DNA methylation on Y chromosome and their associations with total mortality among Chinese males. Aging Cell 21, e13563 (2022).
Google Scholar
Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541–550 (2018).
Google Scholar
Luquette, L. J. et al. A comprehensive view of somatic mosaicism by single-cell DNA analysis. Preprint at bioRxiv https://doi.org/10.1101/2025.10.31.685648 (2025).
Asim, A. et al. Investigation of LOY in prostate, pancreatic, and colorectal cancers in males: a case-control study. Expert. Rev. Mol. Diagn. 20, 1259–1263 (2020).
Google Scholar
Machiela, M. J. et al. Mosaic chromosome Y loss and testicular germ cell tumor risk. J. Hum. Genet. 62, 637–640 (2017).
Google Scholar
Lysiak, M. et al. Deletions on chromosome Y and downregulation of the SRY gene in tumor tissue are associated with worse survival of glioblastoma patients. Cancers https://doi.org/10.3390/cancers13071619 (2021).
Google Scholar
Holmes, R. I. et al. Loss of the Y chromosome in acute myelogenous leukemia: a report of 13 patients. Cancer Genet. Cytogenet. 17, 269–278 (1985).
Google Scholar
Lippert, E. et al. Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy. Haematologica 95, 1604–1607 (2010).
Google Scholar
United Kingdom Cancer Cytogenetics Group (UKCCG). Loss of the Y chromosome from normal and neoplastic bone marrows. Genes Chromosomes Cancer 5, 83–88 (1992).
Google Scholar
Abdelfatah, M. et al. Loss of the Y chromosome predicts lower complete cytogenetic remission rate in patients (pts) with chronic myeloid leukemia (CML). Blood 120, 4804 (2012).
Google Scholar
Raters, V. M. et al. Combined score of Y chromosome loss and T-cell infiltration improves UICC based stratification of esophageal adenocarcinoma. Front. Oncol. 13, 1249172 (2023).
Google Scholar
Loeser, H. et al. Y chromosome loss is a frequent event in barrett’s adenocarcinoma and associated with poor outcome. Cancers https://doi.org/10.3390/cancers12071743 (2020).
Google Scholar
Uchiyama, S. et al. Mosaic loss of chromosome Y characterises late-onset rheumatoid arthritis and contrasting associations of polygenic risk score based on age at onset. Ann. Rheum. Dis. 84, 1313–1323 (2025).
Google Scholar
Goyani, P., Christodoulou, R. & Vassiliou, E. Immunosenescence: aging and immune system decline. Vaccines https://doi.org/10.3390/vaccines12121314 (2024).
Google Scholar
Zhou, W. et al. Mosaic loss of chromosome Y is associated with common variation near TCL1A. Nat. Genet. 48, 563–568 (2016).
Google Scholar
Aviv, A. The “telomereless” erythrocytes and telomere-length dependent erythropoiesis. Aging Cell 22, e13997 (2023).
Google Scholar
Macallan, D. C. et al. B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood 105, 3633–3640 (2005).
Google Scholar
Shen, E. C. et al. Barriers and facilitators for population genetic screening in healthy populations: a systematic review. Front. Genet. 13, 865384 (2022).
Google Scholar
Brownmiller, T. et al. Y chromosome lncRNA are involved in radiation response of male non-small cell lung cancer cells. Cancer Res. 80, 4046–4057 (2020).
Google Scholar
Chen, T. M. et al. KDM5D histone demethylase identifies platinum-tolerant head and neck cancer cells vulnerable to mitotic catastrophe. Int. J. Mol. Sci. https://doi.org/10.3390/ijms24065310 (2023).
Google Scholar
Zhou, W. et al. Loss of the Y chromosome predicts a high relapse risk in younger adult male patients with t(8;21) acute myeloid leukemia on high-dose cytarabine consolidation therapy: a retrospective multicenter study. Leuk. Lymphoma 61, 820–830 (2020).
Google Scholar
You, L. et al. Circulating immunological transcriptomic profile identifies DDX3Y and USP9Y on the Y chromosome as promising biomarkers for predicting response to programmed death 1/programmed death ligand 1 blockade. Chin. Med. J. 138, 364–366 (2025).
Google Scholar
Matsueda, S., Chen, L., Li, H., Yao, H. & Yu, F. Recent clinical researches and technological development in TIL therapy. Cancer Immunol. Immunother. 73, 232 (2024).
Google Scholar
Yao, C. D. & Davis, K. L. Correlative studies reveal factors contributing to successful CAR-T cell therapies in cancer. Cancer Metastasis Rev. 44, 15 (2024).
Google Scholar
Chen, X. et al. Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis. 13, 974 (2022).
Google Scholar
Thompson, J. S. et al. Predicting resistance to chemotherapy using chromosomal instability signatures. Nat. Genet. 57, 1708–1717 (2025).
Google Scholar
Lukow, D. A. et al. Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies. Dev. Cell 56, 2427–2439 (2021).
Google Scholar
Lin, G. T. et al. Combining apatinib and oxaliplatin remodels the immunosuppressive tumor microenvironment and sensitizes desert-type gastric cancer to immunotherapy. Cancer Res. 85, 2117–2133 (2025).
Google Scholar
Turner, A. Membrane alanyl aminopeptidase. Handb. Proteolytic Enzymes 2004, 289–294 (2012).
Zhang, J. et al. CD13 inhibition enhances cytotoxic effect of chemotherapy agents. Front. Pharmacol. 9, 1042 (2018).
Google Scholar
Guo, Q. et al. CD13: a key player in multidrug resistance in cancer chemotherapy. Oncol. Res. 28, 533–540 (2020).
Google Scholar
Wang, J. et al. Impact of Y chromosome loss on the risk of Parkinson’s disease and progression. eBioMedicine 117, 105769 (2025).
Google Scholar
Weyrich, M. et al. Mosaic loss of Y chromosome and mortality after coronary angiography. Eur. Heart J. 46, 1603–1616 (2025).
Google Scholar
Soh, P. X. Y. et al. Y chromosome variation and prostate cancer ancestral disparities. iScience 28, 112437 (2025).
Google Scholar
Wong, A. K. et al. Loss of the Y chromosome: an age-related or clonal phenomenon in acute myelogenous leukemia/myelodysplastic syndrome?. Arch. Pathol. Lab. Med. 132, 1329–1332 (2008).
Google Scholar
Ouseph, M. M. et al. Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells. Haematologica 106, 555–564 (2021).
Google Scholar
Ganster, C. et al. New data shed light on Y-loss-related pathogenesis in myelodysplastic syndromes. Genes Chromosomes Cancer 54, 717–724 (2015).
Google Scholar
Forsberg, L. A. et al. Mosaic loss of chromosome Y in leukocytes matters. Nat. Genet. 51, 4–7 (2019).
Google Scholar
Wilson, P. C. et al. Mosaic loss of Y chromosome is associated with aging and epithelial injury in chronic kidney disease. Genome Biol. 25, 36 (2024).
Google Scholar
Ljubicic, M. L. et al. Clinical but not histological outcomes in males with 45,X/46,XY mosaicism vary depending on reason for diagnosis. J. Clin. Endocrinol. Metab. 104, 4366–4381 (2019).
Google Scholar
Witchel, S. F. Disorders of sex development. Best Pract. Res. Clin. Obstet. Gynaecol. 48, 90–102 (2018).
Google Scholar
White, M. C. et al. Age and cancer risk: a potentially modifiable relationship. Am. J. Prev. Med. 46, S7–S15 (2014).
Google Scholar
Buscheck, F. et al. Y-chromosome loss is frequent in male renal tumors. Ann. Transl. Med. 9, 209 (2021).
Google Scholar
Dorvall, M. et al. Mosaic loss of chromosome Y is associated with functional outcome after ischemic stroke. Stroke 54, 2434–2437 (2023).
Google Scholar
Wallrapp, C. et al. Loss of the Y chromosome is a frequent chromosomal imbalance in pancreatic cancer and allows differentiation to chronic pancreatitis. Int. J. Cancer 91, 340–344 (2001).
Google Scholar
Tong, H. et al. Identification of interleukin-9 producing immune cells in endometrial carcinoma and establishment of a prognostic nomogram. Front. Immunol. 11, 544248 (2020).
Google Scholar
Heim, L. et al. IL-9 producing tumor-infiltrating lymphocytes and treg subsets drive immune escape of tumor cells in non-small cell lung cancer. Front. Immunol. 13, 859738 (2022).
Google Scholar
Sano, S., Thel, M. C. & Walsh, K. Mosaic loss of Y chromosome in white blood cells: its impact on men’s health. Physiology 38, 161–166 (2023).
Google Scholar
Feng, Z., Liao, M. & Zhang, L. Sex differences in disease: sex chromosome and immunity. J. Transl. Med. 22, 1150 (2024).
Google Scholar
Ma, T. et al. Association of hematopoietic loss of Y chromosome with atrial fibrillation incidence and sex disparity. JACC Basic Transl. Sci. 10, 279–289 (2025).
Google Scholar
de Magalhaes, J. P. Distinguishing between driver and passenger mechanisms of aging. Nat. Genet. 56, 204–211 (2024).
Google Scholar
Gargiulo, G., Serresi, M. & Marine, J. C. Cell states in cancer: drivers, passengers, and trailers. Cancer Discov. 14, 610–614 (2024).
Google Scholar
Tang, J. et al. The genomic landscapes of individual melanocytes from human skin. Nature 586, 600–605 (2020).
Google Scholar
Heim, S. et al. Trisomy 7 and sex chromosome loss in human brain tissue. Cytogenet. Cell Genet. 52, 136–138 (1989).
Google Scholar
Pierre, R. V. & Hoagland, H. C. Age-associated aneuploidy: loss of Y chromosome from human bone marrow cells with aging. Cancer 30, 889–894 (1972).
Google Scholar
Seok, J., Kwak, Y., Kim, S., Kim, E. M. & Kim, A. Advances in liquid biopsy for diagnosis of bladder cancer. Int. Neurourol. J. 28, 83–95 (2024).
Google Scholar
Dorrenhaus, A. et al. Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system. Arch. Toxicol. 74, 618–626 (2000).
Google Scholar
Lin, S. Y., Linehan, J. A., Wilson, T. G. & Hoon, D. S. B. Emerging utility of urinary cell-free nucleic acid biomarkers for prostate, bladder, and renal cancers. Eur. Urol. Focus 3, 265–272 (2017).
Google Scholar
Betz, J., Meloni, A. M. & Sandberg, A. A. FISH studies on the Y chromosome in male urinary cells. Cancer Genet. Cytogenet. 88, 155–157 (1996).
Google Scholar
Meloni, A. M. et al. A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors. Cancer Genet. Cytogenet. 71, 105–118 (1993).
Google Scholar
Corkum, C. P. et al. Immune cell subsets and their gene expression profiles from human PBMC isolated by vacutainer cell preparation tube (CPT) and standard density gradient. BMC Immunol. 16, 48 (2015).
Google Scholar
Wang, J. H., Rabkin, C. S., Engels, E. A. & Song, M. Associations between eosinophils and cancer risk in the UK Biobank. Int. J. Cancer 155, 486–492 (2024).
Google Scholar
Glenn, A. & Armstrong, C. E. Physiology of red and white blood cells. Anaesth. Intensive Care Med. 20, 170–174 (2019).
Google Scholar
Mo, H. et al. Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer. Breast 53, 111–118 (2020).
Google Scholar
Thakur, B. K. et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 24, 766–769 (2014).
Google Scholar
Bhat, M. A., Sharma, J. B., Roy, K. K., Sengupta, J. & Ghosh, D. Genomic evidence of Y chromosome microchimerism in the endometrium during endometriosis and in cases of infertility. Reprod. Biol. Endocrinol. 17, 22 (2019).
Google Scholar
Xiao, G. et al. The long noncoding RNA TTTY15, which is located on the Y chromosome, promotes prostate cancer progression by sponging let-7. Eur. Urol. 76, 315–326 (2019).
Google Scholar
Wen, X., Han, W. & Liu, C. Long non-coding RNA TTTY15 silencing inhibits gastric cancer progression by sponging microRNA-98-5p to down-regulate cyclin D2 expression. Bioengineered 13, 7380–7391 (2022).
Google Scholar
Zheng, X. et al. Male-specific long non-coding RNA testis-specific transcript, Y-linked 15 promotes gastric cancer cell growth by regulating Wnt family member 1/beta-catenin signaling by sponging microRNA let-7a-5p. Bioengineered 13, 8605–8616 (2022).
Google Scholar
Lai, I. L. et al. Male-specific long noncoding RNA TTTY15 inhibits non-small cell lung cancer proliferation and metastasis via TBX4. Int. J. Mol. Sci. https://doi.org/10.3390/ijms20143473 (2019).
Google Scholar
Wu, S. et al. A novel micropeptide encoded by Y-linked LINC00278 links cigarette smoking and AR signaling in male esophageal squamous cell carcinoma. Cancer Res. 80, 2790–2803 (2020).
Google Scholar
Liang, W. et al. M(6)A-mediated upregulation of LINC00106 promotes stemness and metastasis properties of hepatocellular carcinoma via sponging Let7f. Front. Cell Dev. Biol. 9, 781867 (2021).
Google Scholar
Ma, D. et al. Exosome-transferred long non-coding RNA ASMTL-AS1 contributes to malignant phenotypes in residual hepatocellular carcinoma after insufficient radiofrequency ablation. Cell Prolif. 53, e12795 (2020).
Google Scholar
